Visceral adiposity as a target for the management of the metabolic syndrome (Q37879666)

24 August 2017

1 reference

title

Visceral adiposity as a target for the management of the metabolic syndrome (English)

1 reference

24 August 2017

1 reference

2

Tohru Funahashi

1 reference

24 August 2017

3

Yuji Matsuzawa

1 reference

24 August 2017

Ken Kishida

1

1 reference

PubMed ID

21612331

24 August 2017

Iichiro Shimomura

series ordinal

4

1 reference

PubMed ID

21612331

24 August 2017

language of work or name

English

0 references

publication date

25 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

44

1 reference

24 August 2017

3

1 reference

24 August 2017

233-241

1 reference

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Obesity and the metabolic syndrome in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal obesity: the cholesterol of the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Type 2 diabetes and the metabolic syndrome in Japanese Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal fat distribution and metabolic risk factors: effects of race.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Is visceral obesity the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Relation of body fat distribution to metabolic complications of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal subcutaneous adipose tissue: a protective fat depot?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal adiposity and insulin resistance in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Abdominal obesity, muscle composition, and insulin resistance in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Regional differences and effect of weight reduction on human fat cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Extreme insulin resistance of the central adipose depot in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

On the control of lipolysis in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Lipid overload and overflow: metabolic trauma and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

The case of visceral fat: argument for the defense

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Lipid accumulation in non-adipose tissue and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Ectopic fat and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Ectopic lipids and organ function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Lipid-induced insulin resistance: unravelling the mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Analysis of an expression profile of genes in the human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Establishment of a concept of visceral fat syndrome and discovery of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Metabolic syndrome: clinical concept and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

One-year reductions in body weight and blood pressure, but not in visceral fat accumulation and adiponectin, improve urinary albumin-to-creatinine ratio in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Salt sensitivity of Japanese from the viewpoint of gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Racial and ethnic modifiers of the salt-blood pressure response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Plasma insulin levels in Japanese and Japanese-American men with type 2 diabetes may be related to the occurrence of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Genetic epidemiology of NIDDM among Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

The metabolic syndrome in East Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

Susceptibility to development of central adiposity among populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2011.564202

10.3109/07853890.2011.564202

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21612331